Italy fines Leadiant EUR3.5 million for charging excessive prices for an orphan drug | Allen & Overy LLP

On 31 May 2022, the Italian Competition Authority (ICA) published its decision sanctioning the pharmaceutical company Leadiant EUR3.5 million for charging excessive prices for the sale...

Related Keywords

Italy ,Netherlands ,United Kingdom ,Spain ,Spanish ,Italian ,Dutch , ,Allen Overy ,Italian Competition Authority ,Dutch Competition Authority ,European Commission ,Spanish Competition Authority ,Italian Medicines Agency ,Italian National Health Service ,Italian Medicines ,Markets Authority ,Commissioner Vestager ,